A comparison of hepatitis C treatment and outcomes at academic, private and Veterans' Affairs treatment centres
Open Access
- 15 December 2003
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 19 (1) , 69-77
- https://doi.org/10.1046/j.1365-2036.2003.01817.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon-??-2b Plus RibavirinDrugs, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Effect of academic affiliation and obstetric volume on clinical outcome and cost of childbirthPublished by Wolters Kluwer Health ,2001
- Impact of the Hawthorne Effect in a Longitudinal Clinical StudyControlled Clinical Trials, 2000
- Racial differences in responses to therapy with interferon in chronic hepatitis CHepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Epidemiology of hepatitis CHepatology, 1997
- Early indicators of prognosis in fulmitant hepatic failure: an assessment of the King's criteriaJournal of Hepatology, 1997
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952